Genetic testing technology is always evolving, and one newer kind of test — that identifies inherited genetic mutations linked to increased risk for colon cancer — may find genetic changes previously missed by earlier methods.
This newer kind of test, called “next generation sequencing panels,” could result in identifying more people with genetic changes that could predispose them to colorectal cancer — and giving these people the opportunity to take steps to lower their risk.
Advancements in genetic testing technology now allow for testing multiple genes associated with hereditary colorectal cancer at one time.
This kind of testing has many benefits, such as the ability to analyze multiple genes at one time, reduced costs, and, in some cases, quicker turnaround time for results.
While initially cautious in the early stages of this testing being used in clinic, we are increasingly using this newer technology to help us to identify more individuals with hereditary colorectal cancer conditions.
As with any genetic testing, we recommend that genetic counseling occur before testing and, when possible, that testing be performed first on someone in the family who has had a related cancer.
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: How a New Colon Cancer Genetic Test Can Catch More Mutations